Loading clinical trials...

A Single-Arm, Virtual Clinical Trial to Evaluate the Effects of a Sleep Supporting Beverage and Two Coffee Substitute Products | Clinical Trials | Clareo Health

COMPLETEDNA

A Single-Arm, Virtual Clinical Trial to Evaluate the Effects of a Sleep Supporting Beverage and Two Coffee Substitute Products

NCT06146517•Clevr Blends

View on ClinicalTrials.gov

Summary

This is a virtual, single-arm clinical trial that will last 12 weeks. Participants will trial three different products, each for 4 weeks. Participants will trial Clevr Blends Sleeptime during weeks 1-4, Clevr Matcha for weeks 5-8, and Clevr Blends Chai for weeks 9-12. Participants will complete questionnaires at Baseline and Week 2, 4, 6, 8, 10, and 12. In addition to data will be collected from participants' sleep tracking devices at Baseline, Week 2, and Week 4.

Eligibility

Age

28 - 42 years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•Female.
•Age 28-42.
•Generally healthy without any uncontrolled or chronic disease.
•Must consume a beverage containing low to moderate amount of caffeine once daily, defined as consuming the caffeine equivalent of less than or equal to one cup of coffee daily.
•Looking for healthier alternatives to caffeine.
•Currently owns a wearable sleep tracking device (e.g. Fitbit, Whoop, Oura etc) and has been wearing consistently for 4 weeks.
•Resident of the USA.

Exclusion Criteria

•Allergies to any of the ingredients in the three products.
•Anyone with a formal diagnosis of insomnia.
•Any pre-existing or chronic conditions that would prevent participants from adhering to the protocol.
•Women that are pregnant, breastfeeding or attempting to conceive during the duration of the trial.
•Unwilling to follow the protocol.
•Participants that consume more than two caffeinated drinks daily.
•Participants that have little to no caffeine daily, equivalent to less than 1 cup of coffee daily.
•Is not a resident of the USA.

Locations (1)

Citruslabs

Santa Monica, California, United States

Key Dates

Start Date

August 31, 2023

Primary Completion Date

January 22, 2024

Completion Date

January 22, 2024

Last Updated

August 22, 2024

Enrollment

ACTUAL participants

Conditions

SleepMoodCaffeine WithdrawalAnxietyProductivity

Interventions

Clevr Sleeptime

OTHER

Clevr Matcha

OTHER

Clevr Chai

OTHER

Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders

NCT01778504

Neuropsychiatric DisorderNeurological Disorder+2 more

View study

RECRUITING

OSA Risk Level in Dental Patients and Correlation With Complications After General Anesthesia

NCT06430957

Obstructive Sleep Apnea Risk ManagementPostoperative Complications+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 22, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Single-Arm, Virtual Clinical Trial to Evaluate the Effects of a Sleep Supporting Beverage and Two Coffee Substitute Products

Inclusion Criteria

Exclusion Criteria

Studying Childhood-onset Behavioral, Psychiatric, and Developmental Disorders

OSA Risk Level in Dental Patients and Correlation With Complications After General Anesthesia

Transcutaneous Auricular Vagus Nerve Stimulation and Spirometry: Sham-Controlled Randomized Trial

MyVitalC: Sleep and Everyday Headache Management

Light Exposure, Migraine Outcomes, and Sleep Quality

Digital-supported Orofacial Myofunctional Therapy in OSA